Sorry for interrupting, but there is something we need to tell you...

We have updated our Cookie Policy to reflect changes in the law on cookies used on websites in Europe. This website uses cookies to maximize your experience and help us to understand how we can improve it. To find out more click here.

Cookies are text files containing small amounts of data which are downloaded to your computer, or other device, when you visit a website. Cookies allow us to recognize your computer and improve your experience on our website. Some cookies are also necessary for the technical operation of our website. Please read our Cookie Policy which provides important information about the cookies we use, how we use them and how they can be deleted. Please remember that deleting cookies may affect your experience of our website.

Show less.

Accept and hide this message
Pillsbury Pillsbury Pillsbury
Pillsbury
Bylined Article

Resolving Life Science Collaboration Disputes
Law360
Authors: Kirke M. Hasson

5/11/2012
Life science companies frequently collaborate to develop drugs or devices. Some collaboration agreements refer disputes to arbitration. Others are silent so any disputes go to court.

On the whole, arbitration works better to resolve disputes that occur during the collaboration, while court litigation works at least as well and maybe better to resolve disputes that occur after the collaboration ceases.

As a result, collaborators should consider agreeing that disputes be submitted to arbitration if the arbitration request is filed before the collaboration terminates or to resolve a dispute about whether the collaboration has been terminated, but that any later disputes proceed to court.

To read this publication in its entirety, please click the link in the adjacent "Download" section.
Pillsbury
Pillsbury Pillsbury Pillsbury